Stock-Based Compensation

$986.70M

TTM · Period ending: Jun 30, 2026 · USD

REGN Stock-Based Compensation

Latest reported$986.70Mperiod endingJun 30, 2026

REGN TTM Stock-Based Comp ($0.00 → $986.70M)

TTM stock-based compensation

High-resolution chart · PNG

REGN stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period ending	Stock-Based Compensation (USD)
Jun 30, 2026	986,700,000
Mar 31, 2026	995,400,000
Dec 31, 2025	993,700,000
Sep 30, 2025	1,048,800,000
Jun 30, 2025	1,036,900,000
Mar 31, 2025	1,008,400,000
Dec 31, 2024	982,800,000
Sep 30, 2024	918,800,000
Jun 30, 2024	897,600,000
Mar 31, 2024	876,400,000
Dec 31, 2023	885,000,000
Sep 30, 2023	876,600,000
Jun 30, 2023	839,000,000
Mar 31, 2023	796,800,000
Dec 31, 2022	725,000,000
Sep 30, 2022	681,400,000
Jun 30, 2022	652,000,000
Mar 31, 2022	637,700,000
Dec 31, 2021	601,700,000
Sep 30, 2021	534,800,000
Jun 30, 2021	499,100,000
Mar 31, 2021	457,100,000
Dec 31, 2020	432,000,000
Sep 30, 2020	444,000,000
Jun 30, 2020	459,900,000
Mar 31, 2020	462,200,000
Dec 31, 2019	464,300,000
Sep 30, 2019	457,548,000
Jun 30, 2019	451,883,000
Mar 31, 2019	452,878,000
Dec 31, 2018	427,400,000
Sep 30, 2018	427,785,000
Jun 30, 2018	441,447,000
Mar 31, 2018	455,910,000
Dec 31, 2017	507,277,000
Sep 30, 2017	534,702,000
Jun 30, 2017	540,984,000
Mar 31, 2017	551,417,000
Dec 31, 2016	559,878,000
Sep 30, 2016	563,712,000
Jun 30, 2016	534,974,000
Mar 31, 2016	497,540,000
Dec 31, 2015	459,049,000
Sep 30, 2015	382,111,000
Jun 30, 2015	353,334,000
Mar 31, 2015	329,589,000
Dec 31, 2014	307,238,000
Sep 30, 2014	280,966,000
Jun 30, 2014	252,846,000
Mar 31, 2014	226,777,000
Dec 31, 2013	198,399,000
Sep 30, 2013	194,524,000
Jun 30, 2013	169,280,000
Mar 31, 2013	144,443,000
Dec 31, 2012	114,657,000
Sep 30, 2012	78,883,000
Jun 30, 2012	71,747,000
Mar 31, 2012	64,537,000
Dec 31, 2011	56,094,000
Sep 30, 2011	54,127,000
Jun 30, 2011	49,553,000
Mar 31, 2011	45,864,000
Dec 31, 2010	39,897,000
Sep 30, 2010	34,988,000
Jun 30, 2010	33,706,000
Mar 31, 2010	32,439,000
Dec 31, 2009	31,259,000
Sep 30, 2009	22,602,000
Jun 30, 2009	15,094,000
Mar 31, 2009	15,868,000
Dec 31, 2008	16,500,000
Sep 30, 2008	16,500,000
Jun 30, 2008	16,500,000
Mar 31, 2008	8,286,000
Dec 31, 2007	6,585,000
Sep 30, 2007	6,585,000
Jun 30, 2007	11,217,000
Mar 31, 2007	15,917,000
Dec 31, 2006	13,411,000
Sep 30, 2006	13,411,000
Jun 30, 2006	8,779,000
Mar 31, 2006	4,079,000
Dec 31, 2005	5,881,000
Sep 30, 2005	5,881,000
Jun 30, 2005	5,881,000
Mar 31, 2005	5,881,000
Dec 31, 2004	671,000
Sep 30, 2004	671,000
Jun 30, 2004	671,000
Mar 31, 2004	671,000
Dec 31, 2003	0
Sep 30, 2003	0
Jun 30, 2003	0
Mar 31, 2003	0
Dec 31, 2002	0
Sep 30, 2002	0
Jun 30, 2002	0
Mar 31, 2002	0
Dec 31, 2001	0
Sep 30, 2001	0